2026. In Silico Pharmacological Evaluation and ADME Profiling of Berberine and Rosmarinic Acid as Potential Inhibitors of Escherichia Coli Dihydrofolate Reductase. Attahadi Medical Journal. (Aug. 2026), 426–431. DOI:https://doi.org/10.69667/amj.26324.